EconPapers    
Economics at your fingertips  
 

Consulting Reports

From Office of Health Economics
Contact information at EDIRC.

Bibliographic data for series maintained by Publications Manager ().

Access Statistics for this working paper series.
Track citations for all items by RSS feed
Is something missing from the series or not right? See the RePEc data check for the archive and series.


001978: Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence
A. Towse and M. Garau
001976: Barriers to Uptake of Minimal Access Surgery in the United Kingdom
Amanda Cole, O'Neill, P., Christopher Sampson and Paula Lorgelly
001944: Review of CRA's Report "Assessing the Economic Impacts of Changing Exemption Provisions During Patent and SPC Protection in Europe"
J. Mestre-Ferrandiz, M. Berdud and A. Towse
001933: Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market
F. Maignen, M. Berdud, G. Hampson and Paula Lorgelly
001932: Routine Funding in the NHS in the UK of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure
B. Zamora, F. Maignen and Paula Lorgelly
001910: Data Governance Arrangements for Real-World Evidence: South Korea
E.k Lee, J.a Park, Amanda Cole and J. Mestre-Ferrandiz
001818: Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries
B. Zamora, F. Maignen, O'Neill, P., J. Mestre-Ferrandiz and M. Garau
001802: Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?
G. Marsden and A. Towse
001784: Policy Options for Formulary Development in Middle-income Countries
K. Hernandez-Villafuerte, M. Garau, A. Towse, L. Garrison and S. Grewal
001781: Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study
K. Hernandez-Villafuerte, M. Garau, T. Towse and L. Garrison
001748: Improving Efficiency and Resource Allocation in Future Cancer Care
Amanda Cole, A. Lundqvist, Paula Lorgelly, H. Norrlid, S. Karlsberg Schaffer, F. Lewis, K. Hernandez-Villafuerte, P. Lindgren, M. Garau, K-O Welin, S. Bianchi, R. Althin, O'Neill, P., U. Persson and A. Towse
001743: Four Case Studies to Explore the Added Value of Oxford AHSN
G. Marsden, A. Martin, B. Zamora, J. Exley, J. Sussex and A. Towse
001699: Shaping Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making
S. Karlsberg Schaffer, Patricia Cubi-Molla, N. Devlin and A. Towse
001688: Assessing Trends in SMC Advice Decisions (October 2009- September 2015)
O'Neill, P. and B. Zamora
001660: Data Governance Arrangements for Real-World Evidence
Amanda Cole, L. Garrison, J. Mestre-Ferrandiz and A. Towse
001645: Estimation of Future Cases of Dementia from Those Born in 2015
F. Lewis
001611: International Comparison of Medicines Usage: Quantitative Analysis from a Swedish Perspective
O'Neill, P. and J. Sussex
001595: Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
A. Chapman and S. Karlsberg Schaffer
001576: Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?
Koonal Shah, A. Chapman, N. Devlin and P. Barnsley
001504: Obstructive Sleep Apnoea: Health Economics Report
J.c Rejon-Parrilla, M. Garau and J. Sussex
000518: The Trajectory of Dementia in the UK - Making a Difference
F. Lewis, S. Karlsberg Schaffer, J. Sussex, O'Neill, P. and L. Cockcroft
000271: The Many Faces of Innovation
Consulting Ohe
000265: Donor Investment Choices: Modeling the Value for Money of Investing in Product Development, Public Private Parnerships as Compared to Other Health Care and Non-Health Care Interventions
A. Gray, P. Fenn, M. Garau, C. Pritchard, E. Godber and A. Towse
000236: Medical Research: What's It Worth?
Office of Health Economics Health Economics Research Group and Europe Rand
000234: Assessment and Appraisal of Oncology Medicines: NICE's Approach and International HTA Experience
M. Garau, Koonal Shah, A. Towse, Q. Wang, M.f Drummond and A. R. Mason
000229: Forward Together: Complementarity of Public and Charitable Research with Respect to Private Research Spending
J. Mestre-Ferrandiz and J. Sussex
000212: Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe
J. Mestre-Ferrandiz, R. Puig-Peiro and A. Towse
000210: The Publicly Funded Vaccines Market in the UK
J. Sussex and Koonal Shah
000206: The Publicly Funded Vaccines Market in Australia
J. Sussex, Koonal Shah and J. Butler
000203: Assessment of the Impact of Orphan Medicinal Products on the European Economy and Society
J. Mestre-Ferrandiz, M. Garau, O'Neill, P. and J. Sussex
000192: The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response
A. Towse, N. Devlin, E. Hawe and L. Garrison
000187: Exploring the Interdependency between Public and Charitable Medical Research
M. Garau, A. Mordoh and J. Sussex
000169: Time Trends in NICE HTA Decisions
O'Neill, P., N. Devlin and R. Puig-Peiro
000154: The Many Faces of Innovation
J. Mestre-Ferrandiz, A. Mordoh and J. Sussex
000144: International Comparisons of Medicines Prices: 2011 Indices
O'Neill, P., R. Puig-Peiro, J. Mestre-Ferrandiz and J. Sussex
000050: The Expanding Value Footprint of Oncology Treatments
J.c Rejon-Parrilla, K. Hernandez-Villafuerte, Koonal Shah, J. Mestre-Ferrandiz, L. Garrison and A. Towse
000001: Health and the Use of Medicines in Primary Care in Wales
L. Baillie, E. Hawe, O'Neill, P. and R. Greville
Page updated 2018-04-21
Sorted by numeric handle